SCHEMBL855235

SCHEMBL855235

OCc1nc(CCl)cs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8861489 0.98 ALDH1A1 (0.47)
SCHEMBL19718384 0.84
SCHEMBL11318891 0.84
SCHEMBL3861801 0.83
SCHEMBL15110978 0.78
SCHEMBL2593156 0.78
SCHEMBL1053330 0.78
Hydrochloric Acid SCHEMBL7094518 0.77 RAB9A (0.54)
Hydrochloric Acid SCHEMBL10425982 0.77 ALDH1A1 (0.43)
SCHEMBL11366303 0.75 SLC6A3 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5700945-A Process for preparing nizatidine TORCAN CHEMICAL LTD. (CA) 1997-12-23 US claimed
US-5541335-A Process for preparing nizatidine TORCAN CHEMICAL LTD. (CA) 1996-07-30 US claimed
CN-102414168-B Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists ACTELION PHARMACEUTICALS LTD 2014-05-21 CN disclosed
CN-101903378-B Aminotriazole derivatives ACTELION PHARMACEUTICALS LTD 2014-03-12 CN disclosed
US-8563714-B2 Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists ACTELION PHARMACEUTICALS LTD. (CH) 2013-10-22 US disclosed
EP-2135867-B1 Trans-9, 10-dehydroepothilone C and trans-9, 10-dehydroepothilone D, analogs thereof and methods of making the same KOSAN BIOSCIENCES INC (US) 2013-09-25 EP disclosed
US-8536209-B2 Aminotriazole derivatives as ALX agonists ACTELION PHARMACEUTICALS LTD. (CH) 2013-09-17 US disclosed
EP-2242743-B1 AMINOPYRAZOLE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2013-08-21 EP disclosed
EP-2432760-B1 BRIDGED SPIRO [2.4] HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2013-07-17 EP disclosed
CN-101903353-B Aminopyrazole derivatives ACTELION PHARMACEUTICALS LTD 2013-04-10 CN disclosed
US-8288419-B2 Aminopyrazole derivatives ACTELION PHARMACEUTICALS, LTD (CH) 2012-10-16 US disclosed
WO-2009077990-A1 AMINOTRIAZOLE DERIVATIVES AS ALX AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-06-25 WO disclosed
CN-101088998-A Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same KOSAN BIOSCIENCES INC (US) 2007-12-19 CN disclosed
CN-1330648-C Trans-9, 10-dehydroepothilones C and D, analogs thereof and methods of making these compounds KOSAN BIOSCIENCES INC (US) 2007-08-08 CN disclosed
CN-1711259-A Trans-9, 10-dehydroepothilones C and D, analogs thereof and methods of making these compounds KOSAN BIOSCIENCES INC (US) 2005-12-21 CN disclosed
EP-1562941-A2 TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHOS OF MAKING THE SAME Kosan Biosciences, Inc. (US) 2005-08-17 EP disclosed
US-20040152708-A1 Trans-9,10-dehydroepothilone C and D, analogs thereof and methods of making the same KOSAN BIOSCIENCES, INC. 2004-08-05 US disclosed
WO-2004043954-A2 TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHOS OF MAKING THE SAME KOSAN BIOSCIENCES INCORPORATED (US) 2004-05-27 WO disclosed
US-5700945-A Process for preparing nizatidine TORCAN CHEMICAL LTD. (CA) 1997-12-23 US disclosed
US-5541335-A Process for preparing nizatidine TORCAN CHEMICAL LTD. (CA) 1996-07-30 US disclosed